S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
SWOG Cancer Research Network
SWOG Cancer Research Network
University of Washington
Providence Health & Services
National Cancer Institute (NCI)
Institut Bergonié
Academic and Community Cancer Research United
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Asan Medical Center
Stanford University
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Asan Medical Center
Canadian Cancer Trials Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Academic and Community Cancer Research United
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Advaxis, Inc.
Amgen
SCRI Development Innovations, LLC
University of Maryland, Baltimore
NSABP Foundation Inc
Wake Forest University Health Sciences
Rutgers, The State University of New Jersey
Jazz Pharmaceuticals
Maimonides Medical Center
Grupo Espanol Multidisciplinario del Cancer Digestivo
Washington University School of Medicine
National Cancer Institute, Naples
M.D. Anderson Cancer Center
University of Florida
Brown University
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
University of Wisconsin, Madison
National Cancer Institute (NCI)
Eli Lilly and Company
Universitaire Ziekenhuizen KU Leuven
Northwestern University
National Cancer Institute (NCI)
University of Iowa
Dana-Farber Cancer Institute
AbbVie
University of California, Irvine
Amgen
Amgen
Radiation Therapy Oncology Group